Janssen AI Investigational Site

Rochester, New York 14620

0 studies enrolling now · 1 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease — Stopped early